Filament Health Corp. (FLHLF)
- Previous Close
0.0377 - Open
0.0374 - Bid --
- Ask --
- Day's Range
0.0348 - 0.0374 - 52 Week Range
0.0320 - 0.2010 - Volume
610 - Avg. Volume
18,660 - Market Cap (intraday)
7.73M - Beta (5Y Monthly) 1.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company. The company propagates psychedelic plants and fungi; conducts genetic research; develops manufacturing technology; generates intellectual property; conducts in-house trials; and distributes drug candidates to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
filament.health13
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: FLHLF
Performance Overview: FLHLF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FLHLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FLHLF
Valuation Measures
Market Cap
7.70M
Enterprise Value
7.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.19
Price/Book (mrq)
4.03
Enterprise Value/Revenue
3.49
Enterprise Value/EBITDA
-1.57
Financial Highlights
Profitability and Income Statement
Profit Margin
-249.75%
Return on Assets (ttm)
-54.66%
Return on Equity (ttm)
-187.23%
Revenue (ttm)
2.13M
Net Income Avi to Common (ttm)
-5.32M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.83M
Total Debt/Equity (mrq)
58.47%
Levered Free Cash Flow (ttm)
-2.35M
Company Insights: FLHLF
FLHLF does not have Company Insights